TATVA vs VALIANTORG: Stock Comparison
TATVA CHIN PHARM CHEM is the larger company by market capitalisation. TATVA CHIN PHARM CHEM shows a higher ROE, a higher dividend yield and faster revenue growth, while VALIANT ORGANICS shows a lower P/E and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
TATVA leads 9; VALIANTORG leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Live Price | ₹1,610.5 | ₹436 |
| Day Change | -0.27% | 0.13% |
| Volume | 913 | 1,734 |
| 52-Week High | ₹2,113.6 | ₹505 |
| 52-Week Low | ₹1,044.1 | ₹195 |
| Distance from 52W High | -23.8% | -13.66% |
Valuation
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Market Cap | ₹3,787 Cr | ₹1,220 Cr |
| P/E Ratio | 60.19x | 22.54x |
| P/B Ratio | 4.65x | 1.61x |
| EPS | ₹9.17 | ₹10.36 |
| Book Value | ₹334.2 | ₹270.87 |
| Dividend Yield | 0.12% | 0% |
Growth
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Revenue Growth (TTM YoY) | 24.4% | 6.9% |
| EPS Growth (TTM YoY) | 907.5% | 269.1% |
| Qtr Sales Growth | 30.09% | 0% |
| Qtr Profit Growth | 34.23% | 0% |
Profitability & Leverage
| Metric | TATVA | VALIANTORG |
|---|---|---|
| ROE | 5.15% | 4.93% |
| ROCE | 4.69% | 5.36% |
| Net Margin | 8.31% | 4.5% |
| Operating Margin | 11.29% | 8.3% |
| Debt to Equity | 0.16x | 0.31x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | TATVA | VALIANTORG |
|---|---|---|
| Promoter Holding | 72.02% | 37.89%▲ 0.02 pp |
| FII Holding | 4.38%▲ 0.45 pp | 0.43%▲ 0.22 pp |
| DII Holding | 3.21%▲ 0.1 pp | 0.03%▲ 0.03 pp |
| Public Holding | 20.39%▼ 0.55 pp | 61.64%▼ 0.28 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: TATVA CHIN PHARM CHEM and VALIANT ORGANICS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.